Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Cash from Investing Activities (2020 - 2025)

Historic Cash from Investing Activities for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Q3 2025 value amounting to -$1.0 million.

  • Insight Molecular Diagnostics' Cash from Investing Activities fell 110689.66% to -$1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.9 million, marking a year-over-year decrease of 86281.41%. This contributed to the annual value of -$512000.0 for FY2024, which is 4506.44% up from last year.
  • According to the latest figures from Q3 2025, Insight Molecular Diagnostics' Cash from Investing Activities is -$1.0 million, which was down 110689.66% from -$349000.0 recorded in Q2 2025.
  • In the past 5 years, Insight Molecular Diagnostics' Cash from Investing Activities ranged from a high of $214000.0 in Q3 2023 and a low of -$8.3 million during Q1 2021
  • For the 5-year period, Insight Molecular Diagnostics' Cash from Investing Activities averaged around -$1.1 million, with its median value being -$394000.0 (2021).
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first skyrocketed by 12491.27% in 2023, then plummeted by 117916.67% in 2025.
  • Quarter analysis of 5 years shows Insight Molecular Diagnostics' Cash from Investing Activities stood at -$401000.0 in 2021, then plummeted by 100.0% to -$802000.0 in 2022, then surged by 112.84% to $103000.0 in 2023, then crashed by 303.88% to -$210000.0 in 2024, then tumbled by 400.0% to -$1.0 million in 2025.
  • Its Cash from Investing Activities was -$1.0 million in Q3 2025, compared to -$349000.0 in Q2 2025 and -$307000.0 in Q1 2025.